Retroviral pseudotransduction for targeted cell manipulation

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• Retroviral vectors are widely used for gene delivery but often lead to permanent transgene integration.
• Controlling the duration and specificity of gene expression remains a challenge in gene therapy applications.

Purpose of the Study:

• To engineer retroviral vectors for transient, receptor-mediated, and dose-controlled delivery of genetic material.
• To investigate the mechanism of gene transfer using modified retroviral vectors that prevent reverse transcription.

Main Methods:

• Generation of mouse leukemia virus-based vectors encoding Cre recombinase with disabled primer binding site function.
• Assessment of transgene insertion, protein expression, and delivery efficiency in targeted cells.
• Analysis of vector components and producer cell requirements for efficient gene transfer.

Main Results:

• Modified vectors achieved highly efficient, receptor-restricted, transient delivery of Cre recombinase.
• Transgene insertion was reduced over 1000-fold, eliminating toxic effects of constitutive expression.
• The mechanism was identified as retroviral messenger RNA (mRNA) transfer, serving as an immediate translation template.

Conclusions:

• Retroviral mRNA transfer offers a method for transient and controlled gene expression in targeted cells.
• This approach facilitates reversible cell manipulation and holds promise for advanced gene therapy strategies.
• The engineered vectors bypass the need for reverse transcription, enhancing safety and control.